MDA Names Susan Schulz as Vice President/Marketing Director
New York, NY - May 18, 2021. The Muscular Dystrophy Association (MDA) has announced the appointment of Susan Schulz as Vice President and Marketing Director, reporting to Chief of Staff Kristine Welker.
“We are thrilled to have Susan join us at MDA,” said Kristine Welker. “Susan’s vast marketing expertise combined with her passion for supporting scientists and scientific research, especially as it pertains to patient care and quality of life for patients and caregivers, will enable her to make an immediate contribution as we work to transform the lives of people affected by neuromuscular diseases.”
Schulz was most recently the marketing director for the New York Academy of Sciences, a 200-year-old non-profit organization dedicated to advancing scientific research, policy, and education. During the five+ years she was there, Schulz oversaw the marketing efforts to promote 60+ scientific symposia and career development events per year, as well as promoting the Academy’s STEM education programs for middle and high school students. She creatively pivoted marketing activities during the pandemic and as a result, achieved a 120% increase in event registrations. In recent years, Schulz has also served as a content consultant for a variety of clients, including consumer and retail brands, media, and finance. Earlier in her career, she was the editor-in-chief of CosmoGIRL, a teen magazine, and editorial brand director for the world-renowned Cosmopolitan, as well as holding earlier editorial positions at beloved household-name-brand magazines Redbook and Good Housekeeping. She lives in Tuckahoe, NY, with her husband and three children.
About the Muscular Dystrophy Association
For 70 years, the Muscular Dystrophy Association (MDA) has been committed to transforming the lives of people living with muscular dystrophy, ALS, and related neuromuscular diseases. We do this through innovations in science and innovations in care. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. MDA's MOVR is the first and only data hub that aggregates clinical, genetic, and patient-reported data for multiple neuromuscular diseases to improve health outcomes and accelerate drug development. MDA supports the largest network of multidisciplinary clinics providing best-in-class care at more than 150 of the nation's top medical institutions. Our Resource Center serves the community with one-on-one specialized support, and we offer educational conferences, events, and materials for families and healthcare providers. MDA Advocacy supports equal access for our community, and each year thousands of children and young adults learn vital life skills and gain independence at summer camp and through recreational programs, at no cost to families. During the COVID-19 pandemic, MDA continues to produce virtual events and programming to support our community when in-person events and activities are not possible. MDA’s COVID-19 guidelines and virtual events are posted at mda.org/COVID19. For more information, visit mda.org.